Abstract
Ribosyl-trans-zeatin has been purified from Vinca rosea L. crown gall tumor tissue by using two new sequences of isolation procedures. Identification of the compound has been established by mass spectrometry, ultraviolet absorbancy spectra, chromatographic values, and growth activity. The isolation sequences eliminate the exposures to pH extremes and the strong cation-exchange resin used in the purification reported earlier. The initial extraction procedures have been designed so as to avoid enzymatic alteration or production of active material and to prevent the inclusion in the extracts of nucleic acids which might serve as soures of the small active compounds. The production of ribosylzeatin by the tumor tissue is confirmed and the validity of isolation steps such as the use of cation exchangers is supported.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Dyson W. H., Hall R. H. N-(Delta-Isopentenyl)adenosine: Its Occurrence as a Free Nucleoside in an Autonomous Strain of Tobacco Tissue. Plant Physiol. 1972 Nov;50(5):616–621. doi: 10.1104/pp.50.5.616. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Miller C. O. Ribosyl-trans-Zeatin, A Major Cytokinin Produced by Crown Gall Tumor Tissue. Proc Natl Acad Sci U S A. 1974 Feb;71(2):334–338. doi: 10.1073/pnas.71.2.334. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Playtis A. J., Leonard N. J. The synthesis of ribosyl-cis-zeatin and thin layer chromatographic separation of the cis and trans isomers of ribosylzeatin. Biochem Biophys Res Commun. 1971 Oct 1;45(1):1–5. doi: 10.1016/0006-291x(71)90041-6. [DOI] [PubMed] [Google Scholar]